# Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock

> **NCT04111822** · PHASE3 · COMPLETED · sponsor: **Cristina Martinez** · enrollment: 40 (actual)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DRUG:** red blood cells transfusion, tranexamic acid (TXA) and fibrinogen concentrate
- **DRUG:** on crystalloid fluid and Tranexamic acid

## Key facts

- **NCT ID:** NCT04111822
- **Lead sponsor:** Cristina Martinez
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-31
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-10-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04111822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04111822, "Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04111822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*